Director Supply Chain & Operations
Noctrix Health
Director Supply Chain & Operations
Noctrix Health
Prescription wearable neuromodulation for RLS.
Noctrix Health is redefining the treatment of chronic neurological disorders with clinically validated therapeutic wearables. Our team of medical device specialists, neuroscientists, and consumer electronics engineers is dedicated to delivering prescription-grade therapy with an outstanding user experience. We have pioneered the world’s first drug-free wearable therapy, clinically proven to alleviate symptoms in adults with drug-resistant Restless Legs Syndrome (RLS). Be part of our mission to transform healthcare, improve lives, and drive meaningful change with Noctrix Health.
We are seeking an experienced and hands-on Director, Supply Chain & Operations to lead and scale Noctrix Health’s supply chain and operations function. This role will have direct ownership of supply planning, supplier and contract manufacturer relationships, inventory strategy, logistics, distribution, and operational readiness to support the company’s continued growth.
The ideal candidate is a strategic operator who is equally comfortable developing long-term supply chain plans and working directly with suppliers, partners, and internal teams to solve immediate operational challenges. This individual will lead and develop the supply chain and operations team while remaining actively involved in planning, supplier management, negotiations, issue resolution, and continuous improvement.
This position reports to the Senior Vice President, Product.
This is a full-time, hybrid position based in Pleasanton, CA, with a minimum of three days onsite per week Travel is expected to be approximately 25%–30%, including international supplier and partner visits as needed.
Prescription wearable neuromodulation for RLS.
Noctrix Health develops a prescription wearable that treats restless legs syndrome through non-pharmacologic neuromodulation. Its NTX100 TOMAC System (Nidra) uses leg bands to stimulate the peroneal nerves at night, producing gentle muscle activation to suppress RLS sensations and improve sleep. It differentiates itself with a clinically validated, prescription-based approach backed by an FDA De Novo clearance after a Breakthrough designation, plus roots in Stanford Biodesign. The goal is to make wearable therapeutics a standard, non-drug option for patients who do not respond to or cannot tolerate medications.
Explore more opportunities at Noctrix Health